Comend Logo
Image
P

PBD Project

Founded in 2021

Peroxisome Biogenesis Disorders (PBD)

We have a focus on Zellweger Spectrum Disorder (ZSD) caused by mutations to the PEX10 gene. Research on PBD has implications for COVID-19, West Nile, Zika, HIV, Alzheimer's, Parkinson's, diabetes, and cancer.

Patient population

  • 1 in 100000 prevalence
  • 100 patients engaged

Disease categories

Loss-of-Function

Causal genes

PEX10
PEX1
PEX5
PEX3
PEX26

About us

PBD Project's mission is to incubate and advance peroxisome science, transforming discovery into treatment by convening leading scientists, funding bold research, and catalyzing the translation of biology into medicines that patients urgently need.

Website

Therapeutics of interest

Gene Therapy (AAV)
Other RNA Therapy
Antisense Oligonucleotide (ASO)
Stem Cell Transplant

Therapeutics in development

Drug Repurposing or Drug Screening
Gene editing
Small molecule
Enzyme or protein replacement
Antisense oligonucleotide (ASO)
Gene therapy (AAV)
Gene therapy (non-AAV)
Drug repurposing

Members

AL

Andrew Longenecker

Research plans

Title
Research strategy
Stage
Status
Partners
Links
Number of projects
Description

PBD pipeline

      7 published projects
      Get updates on our research